A Multicenter, Prospective, Randomized, Controlled Study to Evaluate the Efficacy of Addition of Alogliptin to the Alpha-glucosidase Inhibitors on Glycemic Control in Patients with Type 2 Diabetes mellitus Showing Inadequate Response to Alpha-glucosidase Inhibitors.

Trial Profile

A Multicenter, Prospective, Randomized, Controlled Study to Evaluate the Efficacy of Addition of Alogliptin to the Alpha-glucosidase Inhibitors on Glycemic Control in Patients with Type 2 Diabetes mellitus Showing Inadequate Response to Alpha-glucosidase Inhibitors.

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Nov 2015

At a glance

  • Drugs Alogliptin (Primary) ; Alpha-glucosidase inhibitors
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top